Medicalgorithmics's ROE % for the quarter that ended in Mar. 2026 was -13.47%. Medicalgorithmics's PB Ratio for the quarter that ended in Mar. 2026 was 4.46.
Medicalgorithmics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -3.02%.
Medicalgorithmics ROE % Adjusted to Book Value Related Terms
Medicalgorithmics ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Medicalgorithmics's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicalgorithmics ROE % Adjusted to Book Value Chart
FRA:B8E vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison
For the Medical Devices subindustry, Medicalgorithmics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicalgorithmics ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Medicalgorithmics's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -3.02% mean?
Medicalgorithmics (FRA:B8E) has a ROE % Adjusted to Book Value of -3.02% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medicalgorithmics and its competitors.
Is Medicalgorithmics' ROE % Adjusted to Book Value too high?
Medicalgorithmics' current ROE % Adjusted to Book Value is -3.02%. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' ROE % Adjusted to Book Value compare to ABT and SYK?
Medicalgorithmics' ROE % Adjusted to Book Value of -3.02% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medicalgorithmics and its competitors. Medicalgorithmics's current ROE % Adjusted to Book Value is -3.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (FRA:B8E) has a current ROE % Adjusted to Book Value of -3.02%. The stock's GF Value™ is €6.00, compared to a current price of €5.94 — trading 1% below its estimated fair value. The current ROE % Adjusted to Book Value is -3.02%. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Medicalgorithmics (FRA:B8E), the current ROE % Adjusted to Book Value is -3.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicalgorithmics (FRA:B8E) Overvalued in 2026?
Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued.
The current stock price of €5.94 is trading 1% below its estimated GF Value™ of €6.00.
Key valuation signals for FRA:B8E:
ROE % Adjusted to Book Value: -3.02%
GF Value™: €6.00 vs. price of €5.94 (1% below fair value)
No single metric tells the full story. See the FRA:B8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score
Get the complete analysis for FRA:B8E
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:B8E has been successfully added to your 
